BioReference Awarded CDC Testing Contract for Covid-19
The CDC has chosen BioReference Laboratories as one of the antibody testing and service providers for the national covid-19 serological survey.
Read MorePosted by Melanie Hamilton-Basich | Jul 28, 2020 | Company News |
The CDC has chosen BioReference Laboratories as one of the antibody testing and service providers for the national covid-19 serological survey.
Read MorePosted by Melanie Hamilton-Basich | Jul 23, 2020 | Covid 19, Uncategorized |
A new study used a simple blood test to confirm the findings of a large-scale British trial of steroid use for covid-19 patients.
Read MorePosted by Laurie Bonner | Jul 21, 2020 | Cancer, Molecular Diagnostics |
Sema4 Signal PanCancer, with an approximately 2,200-gene panel, delivers a targeted approach to DNA and RNA sequencing for solid and hematologic cancers.
Read MorePosted by Laurie Bonner | Jul 9, 2020 | Company News, Covid 19 |
Synergy is using two newly developed serology testing assays, one produced by Beckman Coulter and another produced by Siemens Healthcare Diagnostics.
Read MorePosted by Laurie Bonner | Jul 8, 2020 | Covid 19, Uncategorized |
Public health laboratories facing RNA extraction reagent supply shortages are now advised to use the amended protocol.
Read More